InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（9 笔）
内部人交易记录
首席财务官已披露买入
3
已披露卖出
9
T+90 胜率
0%
T+90 平均收益
-14.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Mackaness James H, 首席财务官. Director active across 1 company, notably Soleno Therapeutics INC. Aggregated, 20 disclosures have been logged. Breakdown: 3 buys · 9 sells. Total volume traded: €1.3m. History available since 13 September 2021. The latest transaction was disclosed on 21 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mackaness James H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
28,600 股0Common StockSEC:0001422484-26-000001:0
2,013 股@ US$49.956.0% 占其流量Common StockSEC:0001422484-25-000003:0
1,669 股@ US$65.96917.6% 占其流量Common StockSEC:0001415889-25-009295:0
14,500 股0Common StockSEC:0001415889-25-001935:0
3,762 股@ US$45.365612.2% 占其流量Common StockSEC:0001415889-25-000955:0
7,248 股@ US$49.335823.9% 占其流量Common StockSEC:0001415889-24-024664:0
3,561 股@ US$47.192611.2% 占其流量Common StockSEC:0001415889-24-022650:0
3,858 股@ US$45.476711.9% 占其流量Common StockSEC:0001415889-24-020945:0
100,000 股0Common StockSEC:0001415889-24-019808:0
1,568 股@ US$41.22174.5% 占其流量Common StockSEC:0001415889-24-019269:0
3,104 股@ US$41.12278.8% 占其流量Common StockSEC:0001415889-24-010247:0
56,000 股0Common StockSEC:0001209191-24-001176:0
2,666 股@ US$4.500.8% 占其流量Common StockSEC:0001209191-23-058574:0
15,000 股@ US$2.5952.7% 占其流量Common StockSEC:0001209191-23-058576:0
4,186 股@ US$28.65198.1% 占其流量Common StockSEC:0001209191-23-057320:0
3,205 股@ US$27.02625.8% 占其流量Common StockSEC:0001209191-23-057036:0
29,084 股0Common StockSEC:0001209191-23-032694:0
40,000 股Common StockSEC:0000899243-22-013308:0
标准退出：2022年6月29日 (T+90)
6,060 股@ US$1.650.0003% mcap25.7% 占其流量Common StockSEC:0000899243-21-035862:0
标准退出：2020年9月24日 (T+90)
11,235 股@ US$0.88840.6% 占其流量Common StockSEC:0000899243-21-035864:0
标准退出：2021年12月12日 (T+90)
20 条申报中的 20 条
About Mackaness James H
Mackaness James H is Chief Financial Officer at Soleno Therapeutics INC, listed on XNAS, and is associated with 20 filings in total. Across the 20 sampled filings between 2021-09-14 and 2026-01-23, buys total EUR 17360 and sells total EUR 1269251, with Cession as the modal transaction nature.
